• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

cancer

Posted inInfections, New Drugs, Oncology, Regulatory

Talicia: Highly Effective Eradication Regimen for Helicobacter pylori

by Tanya von Reuss June 5, 2022September 8, 2022

Combination drug invented by RedHill Biopharma will get rid of Helicobacter pylori infection in 90% of patients.

Posted inClinical Trials, COVID-19, Infections, Oncology

Yeliva: New Drug for COVID-19

by Tanya von Reuss and Timur Burkhanayev February 19, 2022September 8, 2022

Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.

Posted inNew Drugs, Oncology, Regulatory

Tivdak: New Drug for Cervical Cancer

by Tanya von Reuss February 3, 2022September 8, 2022

Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.

liver
Posted inOncology, Research

Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma

by Mark Gubar and Timur Burkhanayev January 30, 2022September 8, 2022

Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.

Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma

by Tanya von Reuss January 27, 2022September 8, 2022

Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.

Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Welireg: New Treatment for Tumors in Von Hippel–Lindau Disease

by Tanya von Reuss January 26, 2022September 8, 2022

Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.

PEComa
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Fyarro: First Drug to Treat Perivascular Epithelioid Cell Tumor

by Tanya von Reuss December 4, 2021September 8, 2022

PEComa is a very rare and aggressive subtype of soft tissue sarcoma.

Posts pagination

Newer posts 1 2 3 4 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×